[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337690-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337690-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pan-cancer-analysis-of-sushi-domain-containing-protein-4-susd4-and-validated-in-colorectal-cancer","Pan-cancer analysis of Sushi domain-containing protein 4 (SUSD4) and validated in colorectal cancer","","Sushi domain-containing protein 4 (SUSD4) is a complement regulatory protein that inhibits the complement system and participates in immune regulation, while its role in cancer progression remains unclear. This study performs pan-cancer analyses and finds that SUSD4 expression associates with prognosis across multiple cancer types. Mechanistic analyses link SUSD4 to immune infiltration, immune-related genes, tumor heterogeneity, and diverse cancer pathways. Colorectal cancer validation shows SUSD4 knockdown suppresses cell growth and alters the JAK/STAT pathway, and organoid drug-sensitivity profiling links SUSD4 to Selumetinib, YK-4-279, and Piperlongumine IC50 trends, supporting SUSD4 as a prognostic biomarker and therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pan-cancer-analysis-of-sushi-domain-containing-protein-4-susd4-and-validated-in-colorectal-cancer/337690/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pan-cancer-analysis-of-sushi-domain-containing-protein-4-susd4-and-validated-in-colorectal-cancer/337690.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What biological function does SUSD4 have and how might it relate to immunity?","Question",{"text":63,"@type":64},"SUSD4 is a complement regulatory protein that primarily inhibits the complement system and is involved in immune regulation, suggesting it can influence immune-mediated cancer processes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does SUSD4 expression relate to cancer prognosis across tumor types?",{"text":68,"@type":64},"Pan-cancer results show an association between SUSD4 expression levels and prognosis in multiple cancer types, supported by survival analyses using log-rank testing.",{"name":70,"@type":61,"acceptedAnswer":71},"What validation evidence exists in colorectal cancer, and what pathway is affected?",{"text":72,"@type":64},"In colorectal cancer cell lines, SUSD4 knockdown inhibits cell growth and impacts the JAK/STAT pathway. Organoid drug-sensitivity analyses further show expression-linked trends with the IC50 of Selumetinib, YK-4-279, and Piperlongumine.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337690,1790361557,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","[www.aging-us.com](www.aging-us.com) AGING 2024, Vol. 16, No. 7  \nResearch Paper  \nPan-cancer analysis of Sushi domain-containing protein 4 (SUSD4) and validated in colorectal cancer  \nYuchen Zhong1,2, Chaojing Zheng2, Weiyuan Zhang1,2, Hongyu Wu1, Qian Zhang1, Dechuan Li1, Haixing Ju1, Haiyang Feng1, Yinbo Chen1, Yongtian Fan1, Weiping Chen1, Meng Wang1, Guiyu Wang1,2  \n1Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, Zhejiang, China  \n2 Department of Colorectal Cancer Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150000, Heilongjiang, China  \nCorrespondence to: Meng Wang, Guiyu Wang; [email:](email: wangmeng@zjcc.org.cn)[ ](email: wangmeng@zjcc.org.cn)[wangmeng@zjcc.org.cn](email: wangmeng@zjcc.org.cn), [guiywang@hrbmu.edu.cn](guiywang@hrbmu.edu.cn)[ ](guiywang@hrbmu.edu.cn)[Keywords:](Keywords: complement system)[ complement system](Keywords: complement system), systemic pan-cancer analysis, SUSD4, immune infiltration of tumors, prognosis  \nReceived: May 26, 2023 Accepted: March 12, 2024 Published: April 4, 2024  \nCopyright: © 2024 Zhong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nSushi domain-containing protein 4 (SUSD4) is a complement regulatory protein whose primary function is to inhibit the complement system, and it is involved in immune regulation. The role of SUSD4 in cancer progression has largely remained elusive. SUSD4 was studied across a variety of cancer types in this study. According to the results, there is an association between the expression level of SUSD4 and prognosis in multiple types of cancer. Further analysis demonstrated that SUSD4 expression level was related to immune cell infiltration, immune-related genes, tumor heterogeneity, and multiple cancer pathways. Additionally, we validated the function of SUSD4 in colorectal cancer cell lines and found that knockdown of SUSD4 inhibited cell growth and impacted the JAK/STAT pathway. By characterizing drug sensitivity in organoids, we found that the expression of SUSD4 showed a positive correlation trend with IC50 of Selumetinib, YK-4-279, and Piperlongumine. In conclusion, SUSD4 is a valuable prognostic indicator for diverse types of cancer, and it has the potential to be a target for cancer therapy.  \nINTRODUCTION  \nComplement fragments play a pivotal role in the defense against foreign pathogens, representing a cornerstone of the innate immune system [1] . Moreover, the activation of the complement system contributes significantly to anticancer defense mechanisms, with Sushi domain-containing protein 4 (SUSD4) emerging as a notable regulatory player within this context. Structurally akin to the membrane complement inhibitor CD46, the immunological significance of SUSD4 warrants particular scrutiny, given the pivotal role of its analogous protein, CD46, in T cell functions [2] . Additionally, CD46 is closely associated with IL-10 and TH1 cells, suggesting that SUSD4 may have a similar function to CD46 [3, 4] . Emelie et al. demonstrated that  \ndownregulation of SUSD4 in breast malignancy cells was related to a poor prognosis, and knockdown of SUSD4 in breast malignancy cell lines reduced cell migration and invasion [5, 6] .  \nNevertheless, the exploration of SUSD4 ’s involvement in tumor immunity and prognostic implications across various cancer types remains limited in prior research efforts. Adopting a systematic pan-cancer approach, the present investigation aims to elucidate the multifaceted dynamics of SUSD4 expression levels vis-à-vis cancer prognosis. Leveraging data extraction from diverse databases, coupled with bioinformatics analyses, we endeavor to delineate the intricate interplay between SUSD4 expression and the immune microen","cbCaihAu9lLCatbG","https://ap.wps.com/l/cbCaihAu9lLCatbG","pdf",5659296,28,"English","# Abstract\n# Introduction\n# Results\n## SUSD4 expression level in normal and tumor samples\n## Survival and prognosis analyses","[{\"question\":\"What biological function does SUSD4 have and how might it relate to immunity?\",\"answer\":\"SUSD4 is a complement regulatory protein that primarily inhibits the complement system and is involved in immune regulation, suggesting it can influence immune-mediated cancer processes.\"},{\"question\":\"How does SUSD4 expression relate to cancer prognosis across tumor types?\",\"answer\":\"Pan-cancer results show an association between SUSD4 expression levels and prognosis in multiple cancer types, supported by survival analyses using log-rank testing.\"},{\"question\":\"What validation evidence exists in colorectal cancer, and what pathway is affected?\",\"answer\":\"In colorectal cancer cell lines, SUSD4 knockdown inhibits cell growth and impacts the JAK/STAT pathway. Organoid drug-sensitivity analyses further show expression-linked trends with the IC50 of Selumetinib, YK-4-279, and Piperlongumine.\"}]","Pan-cancer analysis of Sushi domain-containing protein 4 (SUSD4) and validated in colorectal cancer | PDF",1790020171,71,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0504a767d133d13185b752c5105906d4.webp",983,1272,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d78444b1e46ad634522387d69102ce4.webp",982,1270,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e2a278d5fd1409901ddc5ce939825ae4.webp",981,1269,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eed84abb6529769a48e2226ec3a79c88.webp",980,1268]